AAAAAA
Results:
1-13
|
Results: 13
Authors:
DELATOUR F
LEGULUDEC D
CARON F
FAURISSON F
TORLOTIN JC
ROUVEIX B
Citation: F. Delatour et al., EFFECT OF A SINGLE ORAL DOSE OF 2 ERYTHROMYCIN ETHYLSUCCINATE FORMULATIONS ON GASTRIC-EMPTYING IN HEALTHY-VOLUNTEERS - A SCINTIGRAPHIC STUDY, Fundamental and clinical pharmacology, 12(3), 1998, pp. 292-297
Authors:
CARSENTIETESSE H
FARINOTTI R
DURANT J
ROGER PM
DESALVADOR F
BERNARD E
ROUVEIX B
DELLAMONICA P
Citation: H. Carsentietesse et al., PHARMACOKINETIC PARAMETERS AND KILLING RATES IN SERUM OF VOLUNTEERS RECEIVING AMOXICILLIN, CEFADROXIL OR CEFIXIME ALONE OR ASSOCIATED WITH NIFLUMIC ACID OR PARACETAMOL, European journal of drug metabolism and pharmacokinetics, 23(3), 1998, pp. 357-366
Authors:
ROUVEIX B
Citation: B. Rouveix, CLINICAL-PHARMACOLOGY OF CYTOKINES, European cytokine network, 8(3), 1997, pp. 291-293
Authors:
PREVOT MH
JEHL F
ROUVEIX B
Citation: Mh. Prevot et al., PHARMACOKINETICS OF A NEW ORAL FORMULATION OF AMOXICILLIN, European journal of drug metabolism and pharmacokinetics, 22(1), 1997, pp. 47-52
Authors:
STAREC M
SINET M
KODYM P
ROSINA J
FISEROVA A
DESFORGES B
ROUVEIX B
Citation: M. Starec et al., THE EFFECT OF DRUGS ON THE MORTALITY OF MICE INOCULATED WITH FRIEND-LEUKEMIA VIRUS OR TOXOPLASMA-GONDII, Physiologia bohemoslovaca, 46(2), 1997, pp. 107-111
Authors:
CARON F
BOUANICHE M
DELATOUR F
DUCROTTE P
TORLOTIN JC
DENIS P
HUMBERT G
ROUVEIX B
Citation: F. Caron et al., EFFECTS OF 2 ORAL ERYTHROMYCIN ETHYLSUCCINATE FORMULATIONS ON THE MOTILITY OF THE SMALL-INTESTINE IN HUMAN-BEINGS, Antimicrobial agents and chemotherapy, 40(8), 1996, pp. 1796-1800
Authors:
FISCHER A
SCHATZ C
BELAISCH F
CAILLIOT C
CALVO F
CANO JP
GEISEN E
GROSSKOFF C
HAZEBROUCQ G
IMBS JL
JULOU CL
LAGARDE D
LANTELME P
LECOURTOIS P
MANONNI D
ROUVEIX B
TROUVIN M
ZALTA JP",ZORZI
Citation: A. Fischer et al., GENE-THERAPY, Therapie, 50(4), 1995, pp. 369-374
Authors:
VEYRIES ML
SINET M
DESFORGES B
ROUVEIX B
Citation: Ml. Veyries et al., EFFECTS OF MORPHINE ON THE PATHOGENESIS OF MURINE FRIEND RETROVIRUS INFECTION, The Journal of pharmacology and experimental therapeutics, 272(2), 1995, pp. 498-504
Authors:
ROUVEIX B
VEYRIES ML
Citation: B. Rouveix et Ml. Veyries, EFFECTS OF MORPHINE ON THE PATHOGENESIS O F MURINE FRIEND RETROVIRUS INFECTION, Bulletin de l'Academie nationale de medecine, 179(5), 1995, pp. 1069-1080
Authors:
ROUVEIX B
Citation: B. Rouveix, GERMED - MONOCLONAL-ANTIBODIES, MS. Medecine sciences, 10(8-9), 1994, pp. 925-928
Authors:
LEGULUDEC D
DELATOUR F
LEBTAHI R
PEKER MC
DAOU D
MEROUCHE M
ROUVEIX B
Citation: D. Leguludec et al., EFFECTS ON GASTRIC-EMPTYING OF 2 ORAL ERYTHROMYCIN ETHYLSUCCINATE FORMULATIONS - A SCINTIGRAPHIC EVALUATION, The Journal of nuclear medicine, 35(5), 1994, pp. 160000087-160000087
Authors:
GALANAUD P
ROUVEIX B
Citation: P. Galanaud et B. Rouveix, GERMED - MONOCLONAL-ANTIBODIES, MS. Medecine sciences, 9(10), 1993, pp. 1153-1153
Authors:
DAHAN R
JAILLON P
LEHNER JP
CAZOR JL
CLOARECBLANCHARD L
DAHAN R
DUCHIER J
GUINOT P
JAILLON P
LEHNER JP
LOEB F
MACQUINMAVIER C
PUECH A
ROLAND E
ROUVEIX B
TEULEESPIE M
THULLIEZ C
VITOU P
Citation: R. Dahan et al., HOW TO PREDICT THE THERAPEUTIC DOSE RANGE TO BE TESTED IN PHASE-III CLINICAL-TRIALS, Therapie, 48(4), 1993, pp. 297-301
Risultati:
1-13
|